These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10651990)

  • 1. Wavelength and fluence effect on vascular damage with photodynamic therapy on skin.
    Tsoukas MM; González S; Flotte TJ; Anderson RR; Sherwood ME; Kollias N
    J Invest Dermatol; 2000 Feb; 114(2):303-8. PubMed ID: 10651990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive dosimetry for threshold phototoxicity in photodynamic therapy on normal skin: red wavelengths produce more extensive damage than blue at equal threshold doses.
    Tsoukas MM; Lin GC; Lee MS; Anderson RR; Kollias N
    J Invest Dermatol; 1997 Apr; 108(4):501-5. PubMed ID: 9077481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin necrosis due to photodynamic action of benzoporphyrin depends on circulating rather than tissue drug levels: implications for control of photodynamic therapy.
    Lin GC; Tsoukas ML; Lee MS; González S; Vibhagool C; Anderson RR; Kollias N
    Photochem Photobiol; 1998 Oct; 68(4):575-83. PubMed ID: 9796441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 585 and 595 nm laser-induced vascular response of normal in vivo human skin.
    Pikkula BM; Chang DW; Nelson JS; Anvari B
    Lasers Surg Med; 2005 Feb; 36(2):117-23. PubMed ID: 15704165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phototoxicity of photodynamic therapy may be suppressed or enhanced by modulation of the cutaneous vasculature.
    González S; Vibhagool C; Sherwood M; Flotte TJ; Kollias N
    J Photochem Photobiol B; 2000 Sep; 57(2-3):142-8. PubMed ID: 11154080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irradiance and light dose influence histological localization of photodamage induced by photodynamic therapy with aminolaevulinic acid.
    Bissonnette R; Sharfaei S; Viau G; Liu Y
    Br J Dermatol; 2004 Sep; 151(3):653-5. PubMed ID: 15377353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy for cutaneous proliferative vascular tumors in a mouse model.
    Middelkamp-Hup MA; Sánchez-Carpintero I; Kossodo S; Waterman P; González S; Mihm MC; Anderson RR
    J Invest Dermatol; 2003 Sep; 121(3):634-9. PubMed ID: 12925226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of continuous low-irradiance photodynamic therapy in the treatment of chest wall progression of breast cancer.
    Morrison SA; Hill SL; Rogers GS; Graham RA
    J Surg Res; 2014 Dec; 192(2):235-41. PubMed ID: 25043529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.
    Engbrecht BW; Menon C; Kachur AV; Hahn SM; Fraker DL
    Cancer Res; 1999 Sep; 59(17):4334-42. PubMed ID: 10485481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wavelength-dependent effects of benzoporphyrin derivative monoacid ring A in vivo and in vitro.
    Waterfield EM; Renke ME; Smits CB; Gervais MD; Bower RD; Stonefield MS; Levy JG
    Photochem Photobiol; 1994 Oct; 60(4):383-7. PubMed ID: 7991665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6).
    Mori K; Yoneya S; Ohta M; Sano A; Anzai K; Peyman GA; Moshfeghi DM
    Ophthalmology; 1999 Jul; 106(7):1384-91. PubMed ID: 10406627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the in vivo photodynamic threshold dose for photofrin, mono- and tetrasulfonated aluminum phthalocyanine using a rat liver model.
    Farrell TJ; Wilson BC; Patterson MS; Olivo MC
    Photochem Photobiol; 1998 Sep; 68(3):394-9. PubMed ID: 9747595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-fluence CO2 laser irradiation: selective epidermal damage to human skin.
    Kamat BR; Tang SV; Arndt KA; Stern RS; Noe JM; Rosen S
    J Invest Dermatol; 1985 Sep; 85(3):274-8. PubMed ID: 3928767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination.
    van der Veen N; Hebeda KM; de Bruijn HS; Star WM
    Photochem Photobiol; 1999 Dec; 70(6):921-9. PubMed ID: 10628304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular effects of photodynamic therapy.
    Krammer B
    Anticancer Res; 2001; 21(6B):4271-7. PubMed ID: 11908681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of photodynamic occlusion using liposomal Zn(II)-phtalocyanine.
    Schmidt-Erfurth U; Michels S; Indorf L; Eggers R; Birngruber R
    Curr Eye Res; 2005 Jul; 30(7):601-12. PubMed ID: 16020295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental research photodynamic effects in perifocal, oedematous brain tissue.
    Goetz C; Hasan A; Stummer W; Heimann A; Kempski O
    Acta Neurochir (Wien); 2002 Feb; 144(2):173-9; discussion 179. PubMed ID: 11862518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short- and long-term normal tissue damage with photodynamic therapy in pig trachea: a fluence-response pilot study comparing Photofrin and mTHPC.
    Murrer LH; Hebeda KM; Marijnissen JP; Star WM
    Br J Cancer; 1999 May; 80(5-6):744-55. PubMed ID: 10360652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of late dermal necrosis in the pig by treatment with multi-wavelength light.
    Rezvani M; Robbins ME; Hopewell JW; Whitehouse EM
    Br J Radiol; 1993 Feb; 66(782):145-9. PubMed ID: 8457828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo light dose rate effects related to hematoporphyrin derivative photodynamic therapy.
    Gomer CJ; Rucker N; Razum NJ; Murphree AL
    Cancer Res; 1985 May; 45(5):1973-7. PubMed ID: 3986754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.